The results indicate that TUBA1C is a potential diagnostic and prognostic biomarker for HCC, and aberrant expression of TUBA1C significantly altered the proliferation and migration ability of HCC cell lines. This evidence concerns the gene TUBA1C and hepatocellular carcinoma.